90
Views
17
CrossRef citations to date
0
Altmetric
Review

Treatment of age-related macular degeneration: focus on ranibizumab

, , , &
Pages 1-14 | Published online: 07 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

David Callanan, Rahul N Khurana, Raj K Maturi, Sunil Patel, Charles C Wykoff, David Eichenbaum, Arshad M Khanani, Tarek Hassan, Hanh Badger, Shraddha Mehta, Grace Le, Mayssa Attar, Jennifer Seal & Xiao-Yan Li. (2023) Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results. Clinical Ophthalmology 17, pages 1367-1384.
Read now
Roopa Vemala, Bhaskar Gupta & Sobha Sivaprasad. (2010) Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases. Clinical Ophthalmology 4, pages 913-916.
Read now

Articles from other publishers (15)

Leonard M. Coulibaly, Stefan Sacu, Philipp Fuchs, Hrvoje Bogunovic, Georg Faustmann, Christian Unterrainer, Gregor S. Reiter & Ursula Schmidt-Erfurth. (2022) Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)—a phase III, prospective, multicentre, randomized study: design and methods. Eye 37:7, pages 1464-1469.
Crossref
John-Michael Guest, Brett Malbin, Gary Abrams, Anthony Parendo, Shibandri Das, Chinwenwa Okeagu, Bing X. Ross, Ashok Kumar & Xihui Lin. (2022) Accuracy of intravitreal injection volume for aflibercept pre-filled syringe and BD Luer-Lok one-milliliter syringe. International Journal of Retina and Vitreous 8:1.
Crossref
Abdallah Abbas, Ciara O’Byrne, Dun Jack Fu, Gabriella Moraes, Konstantinos Balaskas, Robbert Struyven, Sara Beqiri, Siegfried K. Wagner, Edward Korot & Pearse A. Keane. (2022) Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology.
Crossref
Ramandeep Singh, Rohan Chauhan, Ashish Saxena, Anup Shah, Laxshmi Mondal, Dhananjay Bakhle, Chirag Shah, Arpit Shah, Shashank Deoghare, Neelakant Krishnan & Neelima Godse. (2022) A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis ® in patients with neovascular age-related macular degeneration . Indian Journal of Ophthalmology 70:8, pages 3008.
Crossref
Ozgul Ugurtay, Alev Kockar & Elvan Alper Sengul. (2021) Real Life Data of Treat and Extend Intravitreal Ranibizumab and Aflibercept Therapy in Wet Age-related Macular Degeneration Patients: 3-Year Results. Korean Journal of Ophthalmology 35:4, pages 280-286.
Crossref
Shingo Yasuda, Takayoshi Sumioka, Hiroki Iwanishi, Yuka Okada, Masayasu Miyajima, Kana Ichikawa, Peter S. Reinach & Shizuya Saika. (2021) Loss of sphingosine 1-phosphate receptor 3 gene function impairs injury-induced stromal angiogenesis in mouse cornea. Laboratory Investigation 101:2, pages 245-257.
Crossref
Moeen Riaz & Paul N. Baird. 2017. Advances in Vision Research, Volume I. Advances in Vision Research, Volume I 169 192 .
Monika Kalesinskaitė, Diana Uljanionok & Rasa Liutkevičienė. (2014) Age-related macular degeneration treatment: current view (literature review)Amžinės geltonosios dėmės degeneracijos gydymas: dabartinis požiūris (literatūros apžvalga). Medicinos teorija ir praktika 21:1, pages 43-50.
Crossref
Melanie Lipp, Franziska Bucher, Anand Parthasarathy, Deniz Hos, Jasmine Onderka, Claus Cursiefen & Felix Bock. (2014) Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis. Graefe's Archive for Clinical and Experimental Ophthalmology 252:6, pages 943-949.
Crossref
Patrycja Nowak-Sliwinska, Michel Sickenberg & Hubert van den Bergh. 2014. Photodynamic Therapy. Photodynamic Therapy 213 233 .
Patrycja Nowak-Sliwinska, Hubert van den Bergh, Michel Sickenberg & Adrian H.C. Koh. (2013) Photodynamic therapy for polypoidal choroidal vasculopathy. Progress in Retinal and Eye Research 37, pages 182-199.
Crossref
Stephen Burgess, Gerry McKay & Miles Fisher. (2013) Ranibizumab. Practical Diabetes 30:9, pages 392-393a.
Crossref
Birgit Weingessel, Gregor Hintermayer, Saskia M. Maca, Renate Rauch & Pia Veronika Vecsei-Marlovits. (2012) The significance of early treatment of exudative age-related macular degeneration: 12 months’ resultsDie Wichtigkeit einer frühen Behandlung bei exsudativer altersabhängiger Makuladegeneration – 12 Monats-Ergebnisse. Wiener klinische Wochenschrift 124:21-22, pages 750-755.
Crossref
Raymond M. Schiffelers, Tjitske K. van der Vaart & Gert Storm. (2011) Neovascular Age-Related Macular Degeneration. BioDrugs 25:3, pages 171-189.
Crossref
Karl G. Csaky. (2010) INTERPRETATION OF FDA REGISTRATION CLINICAL TRIALS IN RETINA:CAN WE USE THEM TO GUIDE CLINICAL PRACTICE?. Evidence-Based Ophthalmology 11:3, pages 137-138.
Crossref